Literature DB >> 24510898

Pathway for Parkinson disease.

Quyen Q Hoang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24510898      PMCID： PMC3932922          DOI： 10.1073/pnas.1324284111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

Review 1.  Parkinson's disease. First of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-08       Impact factor: 91.245

2.  GAK: a cyclin G associated kinase contains a tensin/auxilin-like domain.

Authors:  Y Kanaoka; S H Kimura; I Okazaki; M Ikeda; H Nojima
Journal:  FEBS Lett       Date:  1997-01-27       Impact factor: 4.124

3.  GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease.

Authors:  Genta Ito; Takuro Okai; Go Fujino; Kohsuke Takeda; Hidenori Ichijo; Toshiaki Katada; Takeshi Iwatsubo
Journal:  Biochemistry       Date:  2007-02-06       Impact factor: 3.162

4.  BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.

Authors:  Suneil K Kalia; Sang Lee; Patrice D Smith; Li Liu; Stephen J Crocker; Thorhildur E Thorarinsdottir; John R Glover; Edward A Fon; David S Park; Andres M Lozano
Journal:  Neuron       Date:  2004-12-16       Impact factor: 17.173

5.  Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.

Authors:  Andrew B West; Darren J Moore; Saskia Biskup; Artem Bugayenko; Wanli W Smith; Christopher A Ross; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-03       Impact factor: 11.205

Review 6.  LRRK2 in Parkinson's disease: protein domains and functional insights.

Authors:  Ignacio F Mata; William J Wedemeyer; Matthew J Farrer; Julie P Taylor; Kathleen A Gallo
Journal:  Trends Neurosci       Date:  2006-04-17       Impact factor: 13.837

Review 7.  Parkinson's disease: clinical aspects.

Authors:  Thomas Klockgether
Journal:  Cell Tissue Res       Date:  2004-09-08       Impact factor: 5.249

Review 8.  Genetics of Parkinson's disease and parkinsonism.

Authors:  John Hardy; Huaiban Cai; Mark R Cookson; Katrina Gwinn-Hardy; Andrew Singleton
Journal:  Ann Neurol       Date:  2006-10       Impact factor: 10.422

9.  Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.

Authors:  Elisa Greggio; Shushant Jain; Ann Kingsbury; Rina Bandopadhyay; Patrick Lewis; Alice Kaganovich; Marcel P van der Brug; Alexandra Beilina; Jeff Blackinton; Kelly Jean Thomas; Rili Ahmad; David W Miller; Sashi Kesavapany; Andrew Singleton; Andrew Lees; Robert J Harvey; Kirsten Harvey; Mark R Cookson
Journal:  Neurobiol Dis       Date:  2006-06-05       Impact factor: 5.996

10.  Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease.

Authors:  Alexandria Beilina; Iakov N Rudenko; Alice Kaganovich; Laura Civiero; Hien Chau; Suneil K Kalia; Lorraine V Kalia; Evy Lobbestael; Ruth Chia; Kelechi Ndukwe; Jinhui Ding; Mike A Nalls; Maciej Olszewski; David N Hauser; Ravindran Kumaran; Andres M Lozano; Veerle Baekelandt; Lois E Greene; Jean-Marc Taymans; Elisa Greggio; Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-07       Impact factor: 11.205
View more
  6 in total

Review 1.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

Review 2.  Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing.

Authors:  M A Artyukhova; Y Y Tyurina; C T Chu; T M Zharikova; H Bayır; V E Kagan; P S Timashev
Journal:  Free Radic Biol Med       Date:  2019-06-12       Impact factor: 7.376

3.  Heterogeneities in Axonal Structure and Transporter Distribution Lower Dopamine Reuptake Efficiency.

Authors:  Cihan Kaya; Mary H Cheng; Ethan R Block; Tom M Bartol; Terrence J Sejnowski; Alexander Sorkin; James R Faeder; Ivet Bahar
Journal:  eNeuro       Date:  2018-02-05

Review 4.  Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?

Authors:  Sara Redenšek; Maja Trošt; Vita Dolžan
Journal:  Front Aging Neurosci       Date:  2017-02-10       Impact factor: 5.750

5.  Proteomic analysis of the human retina reveals region-specific susceptibilities to metabolic- and oxidative stress-related diseases.

Authors:  Gabriel Velez; Daniel A Machlab; Peter H Tang; Yang Sun; Stephen H Tsang; Alexander G Bassuk; Vinit B Mahajan
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

Review 6.  Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.

Authors:  Ágatha Oliveira-Giacomelli; Yahaira Naaldijk; Laura Sardá-Arroyo; Maria C B Gonçalves; Juliana Corrêa-Velloso; Micheli M Pillat; Héllio D N de Souza; Henning Ulrich
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.